Analysts have set 12-month price targets for Merit Medical Systems, revealing an average target of $114.12, a high estimate ...

Limus-based devices, rather than being a substitute for paclitaxel as they were once seen, are coming of age in peripheral ...

The global peripheral vascular devices market, valued at USD 4.7 billion in 2022, is projected to expand at a robust CAGR of 6.6%, reaching USD 8.9 billion by 2032, according to Future Market Insights ...

R3 Vascular announced that a doctor treated the first patient in the ELITE-BTK pivotal trial of its drug-eluting ...

Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced the publication of the TRANSCEND clinical trial, a global ...

R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce ...

The lawsuit states that Surmodics, Inc. based in Eden Prairie, is the largest provider in the United States of outsourced ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...